Abstract

Preview
The ongoing pandemic of Coronavirus disease 2019 (COVID-19) is severely challenging healthcare systems all around the world, with the need to provide intensive care to a previously inconceivable number of patients.
The clinical spectrum of the disease is very wide, ranging from minor, unspecific symptoms, such as fever, dry cough and diarrhoea, sometimes combined with mild pneumonia and mild dyspnoea, to severe pneumonia with dyspnoea, tachypnoea and disturbed gas exchange, leading in approximately 5% of infected patients to severe lung dysfunction, a need for ventilation, shock or multiple (extra pulmonary) organ failure1. [ … ]

Downloads

Authors

Marco Marietta - Department of Oncology and Haematology, University Hospital, Modena

Walter Ageno - Department of Medicine and Surgery, “Insubria” University, Varese

Andrea Artoni - IRCCS “Ca’ Granda Maggiore” Hospital Foundation, “Angelo Bianchi Bonomi” Haemophilia and Thrombosis Center and “Fondazione Luigi Villa”, Milan

Erica De Candia - Department of Medicine and Translational Surgery, “Università Cattolica del Sacro Cuore”, Faculty of Medicine and Surgery, Rome; Department of Diagnostic Imaging, Oncological Radiotherapy and Haematology, Foundation "A. Gemelli" IRCCS University Hospital, Rome

Paolo Gresele - Department of Medicine, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia

Marina Marchetti - Immunohematology and Transfusion Medicine Department, “ASST Papa Giovanni XXIII”, Bergamo

Rossella Marcucci - Department of Experimental and Clinical Medicine, “Careggi” University Hospital, University of Florence, Italy

Armando Tripodi - IRCCS “Ca’ Granda Maggiore” Hospital Foundation, “Angelo Bianchi Bonomi” Haemophilia and Thrombosis Center and “Fondazione Luigi Villa”, Milan

  • Abstract viewed - 16 times
  • PDF downloaded - 1 times